Anavex Life Sciences's total assets for Q3 2025 were $102.43M, a decrease of -12.56% from the previous quarter. AVXL total liabilities were $11.47M for the fiscal quarter, a -33.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.